{"id":"NCT00092131","sponsor":"Organon and Co","briefTitle":"Montelukast in Exercise-Induced Bronchospasm - 2003 (0476-270)","officialTitle":"A Double-Blind, Randomized, Placebo-Controlled, Multicenter, 2-Period, Crossover Study to Evaluate the Effects of a Single Dose of Montelukast on Exercise-Induced Bronchospasm","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2003-06","primaryCompletion":"2003-11","completion":"2003-11","firstPosted":"2004-09-24","resultsPosted":"2010-06-17","lastUpdate":"2022-02-02"},"enrollment":51,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"DOUBLE","primaryPurpose":"PREVENTION"},"conditions":["Asthma, Exercise-Induced"],"interventions":[{"type":"DRUG","name":"Comparator: Montelukast","otherNames":[]},{"type":"DRUG","name":"Comparator: Placebo","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to determine the effect of an approved medication being studied in support of a new approach in the prevention of exercise-induced asthma (a worsening of asthma caused by exercise, also known as exercise-induced bronchospasm), in participants who have a history of worsening asthma after exercise.","primaryOutcome":{"measure":"Maximum Percent Fall in FEV1 After Exercise Challenge at 2 Hours Postdose Compared With Pre-exercise Baseline in Patients With Exercise-induced Bronchospasm (EIB)","timeFrame":"Pre-exercise baseline measurement and 0-60 minutes after the exercise challenge performed 2 hours after a single oral dose","effectByArm":[{"arm":"Placebo","deltaMin":22.33,"sd":13.1},{"arm":"Montelukast 10 mg","deltaMin":10.8,"sd":7.88}],"pValues":[]},"eligibility":{"minAge":"15 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["16892789"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":25},"commonTop":[]}}